Rise Therapeutics, LLC SBIR Phase II Award, May 2021
A SBIR Phase II contract was awarded to Rise Therapeutics, LLC in May, 2021 for $998,658.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Is a
Award Amount (USD)
998,658
0
Government Branch
Date Awarded
May 12, 2021
0
End Date
April 30, 2024
0
SBIR/STTR Award Recipient
Contract Number (US Government)
1SB1DE030833-01A1
0
Award Phase
Phase II
0
Award Type
SBIR
0
Official Website
Find more entities like Rise Therapeutics, LLC SBIR Phase II Award, May 2021
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.